These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3035079)

  • 21. Preparation of a prototype inactivated hepatitis A virus vaccine from infected cell cultures.
    Binn LN; Bancroft WH; Lemon SM; Marchwicki RH; LeDuc JW; Trahan CJ; Staley EC; Keenan CM
    J Infect Dis; 1986 Apr; 153(4):749-56. PubMed ID: 3005435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An inactivated hepatitis A viral vaccine of cell culture origin.
    Provost PJ; Hughes JV; Miller WJ; Giesa PA; Banker FS; Emini EA
    J Med Virol; 1986 May; 19(1):23-31. PubMed ID: 3009703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis A virus: clones, cultures, and vaccines.
    Ticehurst JR
    Semin Liver Dis; 1986 Feb; 6(1):46-55. PubMed ID: 3012783
    [No Abstract]   [Full Text] [Related]  

  • 24. Antigenic and genetic variation in cytopathic hepatitis A virus variants arising during persistent infection: evidence for genetic recombination.
    Lemon SM; Murphy PC; Shields PA; Ping LH; Feinstone SM; Cromeans T; Jansen RW
    J Virol; 1991 Apr; 65(4):2056-65. PubMed ID: 1705995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of the inactivation kinetics of hepatitis A virus in human plasma products using a simple TCID50 assay.
    Barrett PN; Meyer H; Wachtel I; Eibl J; Dorner F
    J Med Virol; 1996 May; 49(1):1-6. PubMed ID: 8732864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isolation and propagation of hepatitis A virus in hepatoma cell cultures.
    Friedman-Alvermann B; Müller D; Spies K
    Acta Virol; 1985 Dec; 29(6):482-6. PubMed ID: 2869659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Study of human and simian hepatitis A virus isolated by an immunoenzyme method using polyclonal and monoclonal antibodies].
    Karetnyĭ IuV; Andzhaparidze AG; Orlova TM; Balaian MS
    Vopr Virusol; 1989; 34(1):50-3. PubMed ID: 2543140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Temperature and density dependent induction of a cytopathic effect following infection with non-cytopathic HAV strains.
    Wales SQ; Ngo D; Hida K; Kulka M
    Virology; 2012 Aug; 430(1):30-42. PubMed ID: 22608060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Propagation of human hepatitis A virus in a hepatoma cell line.
    Frösner GG; Deinhardt F; Scheid R; Gauss-Müller V; Holmes N; Messelberger V; Siegl G; Alexander JJ
    Infection; 1979; 7(6):303-5. PubMed ID: 232698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simian hepatitis A virus (HAV) strain AGM-27: comparison of genome structure and growth in cell culture with other HAV strains.
    Tsarev SA; Emerson SU; Balayan MS; Ticehurst J; Purcell RH
    J Gen Virol; 1991 Jul; 72 ( Pt 7)():1677-83. PubMed ID: 1649901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation and adaptation characteristics of hepatitis A virus in primary African green monkey kidney cells: production of antigen useful for ELISA serology.
    Wang KQ; Nielsen CM; Vestergaard BF
    Intervirology; 1985; 24(2):99-107. PubMed ID: 2997078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum neutralizing antibody response to hepatitis A virus.
    Lemon SM; Binn LN
    J Infect Dis; 1983 Dec; 148(6):1033-9. PubMed ID: 6317766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis of immunogenic hepatitis A virus particles by recombinant baculoviruses.
    Rosen E; Stapleton JT; McLinden J
    Vaccine; 1993; 11(7):706-12. PubMed ID: 8393604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of complement-dependent cytolytic antibodies in hepatitis A virus infection.
    Gabriel P; Vallbracht A; Flehmig B
    J Med Virol; 1986 Sep; 20(1):23-31. PubMed ID: 3020167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Adaptation of hepatitis A virus strain (JaM-55) originally pathogenic for monkeys to a cell culture].
    Andzhaparidze AG; Orlova TM; Balaian MS; Kusov IuIu
    Mol Gen Mikrobiol Virusol; 1987 May; (5):40-4. PubMed ID: 3039362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies of prototype live hepatitis A virus vaccines in primate models.
    Karron RA; Daemer R; Ticehurst J; D'Hondt E; Popper H; Mihalik K; Phillips J; Feinstone S; Purcell RH
    J Infect Dis; 1988 Feb; 157(2):338-45. PubMed ID: 2826614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inducement of cytopathic changes and plaque formation by porcine haemagglutinating encephalomyelitis virus.
    Sato K; Inaba Y; Miura Y; Tokuhisa S; Matumoto M
    Vet Microbiol; 1983 Nov; 8(6):521-30. PubMed ID: 6659311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic hepatitis A with persistent viral replication.
    Inoue K; Yoshiba M; Yotsuyanagi H; Otsuka T; Sekiyama K; Fujita R
    J Med Virol; 1996 Dec; 50(4):322-4. PubMed ID: 8950689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Propagation of human hepatitis A virus in conventional cell lines.
    Kojima H; Shibayama T; Sato A; Suzuki S; Ichida F; Hamada C
    J Med Virol; 1981; 7(4):273-86. PubMed ID: 6278066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An infectious cDNA clone of a cytopathic hepatitis A virus: genomic regions associated with rapid replication and cytopathic effect.
    Zhang H; Chao SF; Ping LH; Grace K; Clarke B; Lemon SM
    Virology; 1995 Oct; 212(2):686-97. PubMed ID: 7571438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.